首页 > 最新文献

Reproductive health of woman最新文献

英文 中文
Features of gynecological pathology in women with infertility and pathology of the thyroid gland 不孕妇女的妇科病理特点及甲状腺病理
Pub Date : 2022-12-29 DOI: 10.30841/2708-8731.8.2022.273298
Dzhanetti Beraya
The objective: to study the structure of gynecological pathology and the hormonal background in women with infertility and various types of thyroid pathology. Materials and methods. The anamnesis of infertile patients was studied. The women, depending on the pathology of the thyroid gland and the method of fertilization were divided into the following groups: the 1st group included 119 women with infertility without thyroid pathology who became pregnant after the use of assisted reproductive technologies (ART); the 2nd group – 47 patients who became pregnant with the help of ART and in whom antibodies to thyroid peroxidase (anti-TPO antibodies) were detected; the 3rd group – 30 women with compensated hypothyroidism, whose pregnancy occurred with ART; the 4th group – 39 women without thyroid pathology and with spontaneous pregnancy; the 5th group – 128 patients with compensated hypothyroidism and spontaneous pregnancy. The concentrations of the following hormones in the blood plasma in the early follicular phase were determined in all the patients: luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol, prolactin, testosterone, cortisol, 17-hydroxyprogesterone, dehydroepiandrosterone sulfate.Results. There were no significant differences between the women with infertility and thyroid pathology and the patients with spontaneous pregnancy without thyroid pathology regarding the age of menarche onset, the period of regularity onset of the menstrual cycle after menarche. The most frequent disorder of the menstrual cycle in patients of the 1st (26.9 %), 2nd (25.5 %) and 3rd (26.6 %) groups was dysmenorrhea. Oligomenorrhea was more often detected in women with infertility and thyroid pathology who became pregnant with the help of ART (25.5 % of patients in the 2nd group and 23.3% – in the 3rd group), compared to women with spontaneous pregnancy. The endocrine factor of infertility was most often determined in women with infertility who became pregnant after ART and had thyroid pathology: in the presence of anti-TPO antibodies, this factor was found in 29.8 % of women, hypothyroidism – 23.3 %. External genital endometriosis as a cause of infertility prevailed among patients with infertility without thyroid pathology, who became pregnant after ART (34.4 %), and women with compensated hypothyroidism, whose pregnancy occurred with the help of ART (26.6 %). In patients with infertility and anti-TPO antibodies, who became pregnant after ART, a significant increase of LH concentration was found compared to the patients with spontaneous pregnancy without thyroid diseases. A significant increase of FSH level was also determined in women of the 1st group compared to healthy patients with spontaneous pregnancy. Conclusions. In women with infertility and various types of thyroid pathology the disorders of the ovarian-menstrual cycle such as dysmenorrhea and oligomenorrhea are typical. The main factor of infertility in patients without thyroid disea
目的:研究不孕妇女的妇科病理结构和激素背景,以及各种类型的甲状腺病理。材料和方法。对不孕症患者的记忆进行了研究。根据甲状腺病理和受精方式将妇女分为以下两组:第一组包括119名使用辅助生殖技术(ART)后怀孕的无甲状腺病理的不孕妇女;第二组:47例接受ART治疗的孕妇,检测出甲状腺过氧化物酶抗体(抗tpo抗体);第三组:30名接受ART治疗的代偿性甲状腺功能减退妇女;第四组:无甲状腺病变、自然妊娠的妇女39例;第五组:代偿性甲状腺功能减退伴自然妊娠128例。测定所有患者卵泡早期血浆中促黄体生成素(LH)、促卵泡激素(FSH)、雌二醇、催乳素、睾酮、皮质醇、17-羟孕酮、硫酸脱氢表雄酮的浓度。有甲状腺病理的不孕症患者与无甲状腺病理的自然妊娠患者在月经初潮发生的年龄、月经初潮后月经周期的正常开始时间等方面均无显著差异。第1组(26.9%)、第2组(25.5%)和第3组(26.6%)患者月经周期紊乱最常见的是痛经。与自然妊娠的妇女相比,在ART帮助下怀孕的不孕症和甲状腺病变妇女中(第二组患者占25.5%,第三组患者占23.3%)更常发现月经稀少。不孕的内分泌因素最常在ART后怀孕并有甲状腺病理的不孕妇女中确定:在抗tpo抗体存在的情况下,该因素在29.8%的妇女中发现,甲状腺功能减退- 23.3%。外生殖器子宫内膜异位症是不孕不育的主要原因,无甲状腺病理的不孕不育患者在ART后怀孕(34.4%),代偿性甲状腺功能减退患者在ART的帮助下怀孕(26.6%)。不孕和抗tpo抗体的患者在ART后怀孕,与无甲状腺疾病的自然妊娠患者相比,LH浓度明显升高。与自然妊娠的健康患者相比,第一组妇女的FSH水平也有显著升高。结论。在患有各种类型甲状腺病理的不孕妇女中,卵巢-月经周期紊乱如痛经和少经是典型的。在没有甲状腺疾病的患者中,不孕的主要因素是外生殖器子宫内膜异位症,这是甲状腺病理患者的一种内分泌因素。在不孕和各种类型甲状腺病理的妇女中,在月经周期的卵泡期血浆中黄体生成素浓度显著增加。
{"title":"Features of gynecological pathology in women with infertility and pathology of the thyroid gland","authors":"Dzhanetti Beraya","doi":"10.30841/2708-8731.8.2022.273298","DOIUrl":"https://doi.org/10.30841/2708-8731.8.2022.273298","url":null,"abstract":"The objective: to study the structure of gynecological pathology and the hormonal background in women with infertility and various types of thyroid pathology. Materials and methods. The anamnesis of infertile patients was studied. The women, depending on the pathology of the thyroid gland and the method of fertilization were divided into the following groups: the 1st group included 119 women with infertility without thyroid pathology who became pregnant after the use of assisted reproductive technologies (ART); the 2nd group – 47 patients who became pregnant with the help of ART and in whom antibodies to thyroid peroxidase (anti-TPO antibodies) were detected; the 3rd group – 30 women with compensated hypothyroidism, whose pregnancy occurred with ART; the 4th group – 39 women without thyroid pathology and with spontaneous pregnancy; the 5th group – 128 patients with compensated hypothyroidism and spontaneous pregnancy. The concentrations of the following hormones in the blood plasma in the early follicular phase were determined in all the patients: luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol, prolactin, testosterone, cortisol, 17-hydroxyprogesterone, dehydroepiandrosterone sulfate.Results. There were no significant differences between the women with infertility and thyroid pathology and the patients with spontaneous pregnancy without thyroid pathology regarding the age of menarche onset, the period of regularity onset of the menstrual cycle after menarche. The most frequent disorder of the menstrual cycle in patients of the 1st (26.9 %), 2nd (25.5 %) and 3rd (26.6 %) groups was dysmenorrhea. Oligomenorrhea was more often detected in women with infertility and thyroid pathology who became pregnant with the help of ART (25.5 % of patients in the 2nd group and 23.3% – in the 3rd group), compared to women with spontaneous pregnancy. The endocrine factor of infertility was most often determined in women with infertility who became pregnant after ART and had thyroid pathology: in the presence of anti-TPO antibodies, this factor was found in 29.8 % of women, hypothyroidism – 23.3 %. External genital endometriosis as a cause of infertility prevailed among patients with infertility without thyroid pathology, who became pregnant after ART (34.4 %), and women with compensated hypothyroidism, whose pregnancy occurred with the help of ART (26.6 %). In patients with infertility and anti-TPO antibodies, who became pregnant after ART, a significant increase of LH concentration was found compared to the patients with spontaneous pregnancy without thyroid diseases. A significant increase of FSH level was also determined in women of the 1st group compared to healthy patients with spontaneous pregnancy. Conclusions. In women with infertility and various types of thyroid pathology the disorders of the ovarian-menstrual cycle such as dysmenorrhea and oligomenorrhea are typical. The main factor of infertility in patients without thyroid disea","PeriodicalId":21003,"journal":{"name":"Reproductive health of woman","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79721579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Basic principles and structure of risk assessment of Great obstetrical syndromes 产科大综合征风险评估的基本原则和结构
Pub Date : 2022-12-29 DOI: 10.30841/2708-8731.8.2022.273294
N. Lemish
The objective: to develop a method for predicting the individual risk for great obstetric syndromes (GOS).Materials and methods. An analysis of the somatic, reproductive, and obstetric anamnesis was conducted in 572 pregnant women with clinical manifestations of GOS, in 81 of them (prediction group) signs of placental dysfunction were detected based on clinical, functional, laboratory, and ultrasound data. Control group (CG) – 50 practically healthy pregnant women with a favorable reproductive history and an uncomplicated course of this pregnancy.Functional, biophysical, hormonal, immunological and hemocoagulation indicators were calculated to determine the informative (prognostic) significance. Quantitative signs were divided into diagnostic intervals, and qualitative signs were assigned a code. The following indicators were included in the standard protocol: age, data on somatic and gynecological history, data on the pregnancy course, results of functional and laboratory examinations. Statistical processing of research results was carried out using standard Microsoft Excel 5.0 and Statistica 6.0 programs. Results. In the I trimester of pregnancy the concentration of placental lactogen (PL) in the prediction group was 29.4 % lower than the CG indicator, estradiol (E2) amount – by 27.4 %, estriol (E3) – by 28.6 %, progesterone (PG) – by 34.4%, human chorionic gonadotropin (hCG) – by 28.3 % lower, and cortisol (CR) – by 36.1 % higher. At the beginning of the II trimester of pregnancy in the prediction group the level of PL was already reduced by 33.8 %, E2 – by 26.2 %, E3 – by 32.3 %, PG – by 37.4 %, hCG – by 30.6 %, and CR – increased by 43.6 % compared to CG.The indicators of placenta hormonal activity in the early stages of pregnancy and at the beginning of the II trimester can be prognostic signs of further disruption of the adaptive compensatory and adaptive reactions of the fetal placental complex (FPC) in the II and III trimesters of pregnancy. Among a wide range of hemostasiological indicators in the I trimester of pregnancy in the prediction group the most informative were: activated partial thromboplastin time (-23 %) and activated recalcification time (+16.2 %), the changes of which remained at the beginning of the II trimester (-40% and - 11.7% respectively). During the evaluation of thromboelastogram data, the value of “r+k” was fixed by 33.3 % lower in the I trimester and by 36 % – at the beginning of the II trimester of pregnancy. As a result of the analysis the indicators with a high information value (more than 3.0 c.u.) were selected for quantitative assessment of the degree of individual risk for the development of maladaptive disorders in the FPC. The clinical trial of the scoring method of prediction proved its high sensitivity (91.8 %) and specificity (85.6 %). Conclusions. A multi-faceted analysis of anamnestic data, features of the pregnancy course, basic clinical, laboratory and functional indicators in women with clinical
目的:发展一种预测大产科综合征个体风险的方法。材料和方法。对572例临床表现为GOS的孕妇进行躯体、生殖和产科记忆分析,其中81例(预测组)通过临床、功能、实验室和超声资料检测出胎盘功能障碍征象。对照组(CG) - 50名实际健康的孕妇,生育史良好,妊娠过程简单。计算功能、生物物理、激素、免疫和凝血指标,以确定信息(预后)意义。定量标志被划分为诊断区间,定性标志被分配一个代码。标准方案包括以下指标:年龄、躯体和妇科病史数据、妊娠过程数据、功能和实验室检查结果。采用标准的Microsoft Excel 5.0和Statistica 6.0程序对研究结果进行统计处理。结果。在妊娠早期,预测组胎盘乳原(PL)浓度比CG指标低29.4%,雌二醇(E2)含量低27.4%,雌三醇(E3)含量低28.6%,黄体酮(PG)含量低34.4%,人绒毛膜促性腺激素(hCG)含量低28.3%,皮质醇(CR)含量高36.1%。与CG相比,预测组妊娠早期PL水平已降低33.8%,E2 -降低26.2%,E3 -降低32.3%,PG -降低37.4%,hCG -降低30.6%,CR -升高43.6%。妊娠早期和妊娠中期初期胎盘激素活性指标可作为妊娠中期和妊娠中期胎儿胎盘复合体(FPC)适应性代偿和适应性反应进一步中断的预后信号。在广泛的止血指标中,预测组妊娠1个月最具信息性的是:活化的部分凝血活素时间(- 23%)和活化的再钙化时间(+ 16.2%),其变化在妊娠2个月开始时保持不变(分别为-40%和- 11.7%)。在评估血栓弹性图数据时,“r+k”的值在妊娠1个月固定低33.3%,在妊娠2个月开始时固定低36%。通过分析,选择具有较高信息价值(大于3.0 c.u.)的指标,定量评价FPC个体发生适应不良障碍的风险程度。预测评分法的临床试验证明其具有较高的敏感性(91.8%)和特异性(85.6%)。结论。通过对有GOS临床表现的妇女的记忆资料、妊娠过程特征、基本临床、实验室和功能指标的多方面分析,可以建立一种有效的方法来预测GOS发展的风险,具有高水平的敏感性和特异性。
{"title":"Basic principles and structure of risk assessment of Great obstetrical syndromes","authors":"N. Lemish","doi":"10.30841/2708-8731.8.2022.273294","DOIUrl":"https://doi.org/10.30841/2708-8731.8.2022.273294","url":null,"abstract":"The objective: to develop a method for predicting the individual risk for great obstetric syndromes (GOS).Materials and methods. An analysis of the somatic, reproductive, and obstetric anamnesis was conducted in 572 pregnant women with clinical manifestations of GOS, in 81 of them (prediction group) signs of placental dysfunction were detected based on clinical, functional, laboratory, and ultrasound data. Control group (CG) – 50 practically healthy pregnant women with a favorable reproductive history and an uncomplicated course of this pregnancy.Functional, biophysical, hormonal, immunological and hemocoagulation indicators were calculated to determine the informative (prognostic) significance. Quantitative signs were divided into diagnostic intervals, and qualitative signs were assigned a code. The following indicators were included in the standard protocol: age, data on somatic and gynecological history, data on the pregnancy course, results of functional and laboratory examinations. Statistical processing of research results was carried out using standard Microsoft Excel 5.0 and Statistica 6.0 programs. Results. In the I trimester of pregnancy the concentration of placental lactogen (PL) in the prediction group was 29.4 % lower than the CG indicator, estradiol (E2) amount – by 27.4 %, estriol (E3) – by 28.6 %, progesterone (PG) – by 34.4%, human chorionic gonadotropin (hCG) – by 28.3 % lower, and cortisol (CR) – by 36.1 % higher. At the beginning of the II trimester of pregnancy in the prediction group the level of PL was already reduced by 33.8 %, E2 – by 26.2 %, E3 – by 32.3 %, PG – by 37.4 %, hCG – by 30.6 %, and CR – increased by 43.6 % compared to CG.The indicators of placenta hormonal activity in the early stages of pregnancy and at the beginning of the II trimester can be prognostic signs of further disruption of the adaptive compensatory and adaptive reactions of the fetal placental complex (FPC) in the II and III trimesters of pregnancy. Among a wide range of hemostasiological indicators in the I trimester of pregnancy in the prediction group the most informative were: activated partial thromboplastin time (-23 %) and activated recalcification time (+16.2 %), the changes of which remained at the beginning of the II trimester (-40% and - 11.7% respectively). During the evaluation of thromboelastogram data, the value of “r+k” was fixed by 33.3 % lower in the I trimester and by 36 % – at the beginning of the II trimester of pregnancy. As a result of the analysis the indicators with a high information value (more than 3.0 c.u.) were selected for quantitative assessment of the degree of individual risk for the development of maladaptive disorders in the FPC. The clinical trial of the scoring method of prediction proved its high sensitivity (91.8 %) and specificity (85.6 %). Conclusions. A multi-faceted analysis of anamnestic data, features of the pregnancy course, basic clinical, laboratory and functional indicators in women with clinical","PeriodicalId":21003,"journal":{"name":"Reproductive health of woman","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80053433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sleep disorders and effectiveness of various methods of insomnia therapy in pregnant women (Literature review) 孕妇睡眠障碍及各种失眠治疗方法的疗效分析(文献综述)
Pub Date : 2022-12-29 DOI: 10.30841/2708-8731.8.2022.273301
О.V. Golyanovskiy, S. V. Frolov
Sleep disorders (dyssomnia) during pregnancy are of high prevalence and may be associated with negative peri- and postnatal outcomes. However, these conditions are often not effectively diagnosed and treated. In this review a systematic evaluation of the effectiveness of different methods of therapy to improve the quality of sleep and in the presence of insomnia during pregnancy was conducted.Systematic search in PubMed, Psycinfo and Medline databases was conducted without limiting the publication date till November 3, 2022. The relevant studies included pregnant women of any age and gestation; they included the clinical intervention schemes aimed at improving sleep quality; the data before and after treatment for one or more sleep-related results were reported. 16 studies were selected with a total of 988 pregnant women. According to the results of researches the effectiveness of different types of interventions was established: cognitive-behavioral therapy for sleep disorders, pharmacotherapy, acupuncture, yoga, relaxation and phytotherapy. The recent publications have determined that sleep disorders have a connection with the adverse pregnancy outcomes, including fetal growth restriction, premature births, weakness of uterine labor activity and high delivery frequency of caesarean section.There is an extremely high relevance and need for high-quality randomized controlled studies about sleep disorders during pregnancy and implementation of effective standard obstetric care programs. There is a necessity to improve psychological care and sleep care during pregnancy to maintain a positive pregnancy course, childbirth and postpartum period. Future clinical studies should be randomized and include a sufficient number of women for statistical efficacy, including checking the effectiveness of cognitive-behavioral insomnia therapy to prevent pregnancy/childbirth complications and somatic diseases in the long-term period.
妊娠期睡眠障碍(睡眠障碍)的患病率很高,可能与负面的围产后结局有关。然而,这些情况往往不能得到有效的诊断和治疗。在这篇综述中,系统地评估了不同的治疗方法的有效性,以改善睡眠质量和在怀孕期间失眠的存在。系统检索PubMed、Psycinfo和Medline数据库,不将发表日期限制在2022年11月3日。相关研究包括任何年龄和妊娠期的孕妇;其中包括旨在改善睡眠质量的临床干预方案;报告了治疗前后一项或多项睡眠相关结果的数据。16项研究共纳入988名孕妇。根据研究结果,确立了不同类型干预措施的有效性:认知行为疗法、药物疗法、针灸疗法、瑜伽、放松疗法和植物疗法。最近的研究表明,睡眠障碍与胎儿生长受限、早产、子宫分娩活动弱和剖宫产率高等不良妊娠结局有关。对妊娠期睡眠障碍的高质量随机对照研究和有效的标准产科护理方案的实施具有极高的相关性和必要性。有必要加强孕期的心理护理和睡眠护理,以保持孕期、分娩和产后的良好状态。未来的临床研究应随机化,纳入足够数量的妇女进行统计疗效,包括检查认知行为失眠治疗在长期内预防妊娠/分娩并发症和躯体疾病的有效性。
{"title":"Sleep disorders and effectiveness of various methods of insomnia therapy in pregnant women (Literature review)","authors":"О.V. Golyanovskiy, S. V. Frolov","doi":"10.30841/2708-8731.8.2022.273301","DOIUrl":"https://doi.org/10.30841/2708-8731.8.2022.273301","url":null,"abstract":"Sleep disorders (dyssomnia) during pregnancy are of high prevalence and may be associated with negative peri- and postnatal outcomes. However, these conditions are often not effectively diagnosed and treated. In this review a systematic evaluation of the effectiveness of different methods of therapy to improve the quality of sleep and in the presence of insomnia during pregnancy was conducted.Systematic search in PubMed, Psycinfo and Medline databases was conducted without limiting the publication date till November 3, 2022. The relevant studies included pregnant women of any age and gestation; they included the clinical intervention schemes aimed at improving sleep quality; the data before and after treatment for one or more sleep-related results were reported. 16 studies were selected with a total of 988 pregnant women. According to the results of researches the effectiveness of different types of interventions was established: cognitive-behavioral therapy for sleep disorders, pharmacotherapy, acupuncture, yoga, relaxation and phytotherapy. The recent publications have determined that sleep disorders have a connection with the adverse pregnancy outcomes, including fetal growth restriction, premature births, weakness of uterine labor activity and high delivery frequency of caesarean section.There is an extremely high relevance and need for high-quality randomized controlled studies about sleep disorders during pregnancy and implementation of effective standard obstetric care programs. There is a necessity to improve psychological care and sleep care during pregnancy to maintain a positive pregnancy course, childbirth and postpartum period. Future clinical studies should be randomized and include a sufficient number of women for statistical efficacy, including checking the effectiveness of cognitive-behavioral insomnia therapy to prevent pregnancy/childbirth complications and somatic diseases in the long-term period.","PeriodicalId":21003,"journal":{"name":"Reproductive health of woman","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74258754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Probable clinical and paraclinical factors of the occurrence of gestational hypertensive disorders in pregnant women after the use of assisted reproductive technologies 使用辅助生殖技术后孕妇发生妊娠期高血压疾病的可能临床及旁临床因素
Pub Date : 2022-12-29 DOI: 10.30841/2708-8731.8.2022.273300
O.V. Islamova, M. Kyrylchuk, L. Bulyk
The objective: to establish probable clinical and paraclinical risk factors for the development of gestational hypertensive disorders (GHD) in pregnant women after the use of assisted reproductive technologies (ART).Materials and methods. A clinical and statistical analysis of the birth histories of 362 women who became pregnant after the use of ART was carried out. Among them, 103 patients with had pre-gestational arterial hypertension (AH) and were included in the 1st group, 51 patients with increased blood pressure for the first time after 20 weeks of pregnancy – GHD, were included in the 2nd group, and 208 women without hypertensive disorders (HD) neither before nor after pregnancy were included in the 3rd group (control one). To determine the prognostic value of probable clinical and paraclinical risk factors for the GHD development in patients after ART, the following factors were analyzed: place of residence, age during pregnancy, obstetric, gynecological and reproductive history, marriage status, body mass index. The assess of commonly known factors was also evaluated for the risk of development for GHD. The influence of method of artificial insemination is also considered.Statistical processing of the results was carried out using standard Microsoft Excel 7.0 and “Statistica 6.0” programs. Results. The research demonstrated that HD is a common complication in pregnant women after the use of ART and accounts for 42.5 %. The frequency of women ≥40 years old was significantly higher in the 1st (42.8 %) and 2nd (25.5 %) groups than in the 3d one (15.5 %), as well as the prevalence of secondary infertility among the examined female patients – 23.3 %, 37.2 % and 6.3 %, respectively. Diabetes was found in women of the 1st (7.8 %) and 2nd (5.9 %) groups statistically more often compared to the control group (1.9 %), multiple pregnancy – in 45.6 %, 52.9 % and 27.0 % cases, respectively; 11.8% of patients in the 2nd group were diagnosed with autoimmune diseases.In patients with pregestational AH and GHD there was the high frequency of secondary infertility which is significantly more compared to the control group (p<0.05). Therefore, it can be assumed that this factor may influence the development of GHD in the future.The use of donor eggs was significantly more frequent in women of the 2nd group (21.5 %) compared to patients of the 1st (4.9 %) and control (5.3 %) groups (p<0.05). Transfer of cryopreserved embryos was used in 54.3 % of pregnant women of the 1st group and in 45.1 % of pregnant women in the 2nd group, which is reliable compared to the indicators of the control group (17.7 %; p<0.05). This makes possible to state that the use of donor eggs and the transfer of cryopreserved embryos can lead to an increase in the risk of GHD development in the future.In the group of pregnant women with pregestational AH, there were significantly more patients with an intergenetic interval of 10 years or more. This suggests that a large intergenetic int
目的:确定使用辅助生殖技术(ART)后孕妇妊娠期高血压疾病(GHD)发展的可能临床和临床旁危险因素。材料和方法。对使用抗逆转录病毒治疗后怀孕的362名妇女的生育史进行了临床和统计分析。其中,103例妊娠前动脉高血压(AH)患者被纳入第一组,51例妊娠20周后首次血压升高(GHD)患者被纳入第二组,208例妊娠前后无高血压疾病(HD)的女性被纳入第三组(对照组)。为确定抗逆转录病毒治疗后GHD发生的可能临床和临床旁危险因素的预后价值,分析以下因素:居住地、妊娠年龄、产科、妇科和生殖史、婚姻状况、体重指数。对常见因素的评估也评估了发展为GHD的风险。同时也考虑了人工授精方式的影响。使用标准的Microsoft Excel 7.0和“Statistica 6.0”程序对结果进行统计处理。结果。研究表明,HD是使用ART后孕妇的常见并发症,占42.5%。年龄≥40岁的第1组(42.8%)和第2组(25.5%)明显高于第3组(15.5%),女性患者继发性不孕症发生率分别为23.3%、37.2%和6.3%。与对照组(1.9%)相比,第1组(7.8%)和第2组(5.9%)的糖尿病发生率更高,多胎妊娠分别为45.6%、52.9%和27.0%;第二组有11.8%的患者被诊断为自身免疫性疾病。妊娠期AH和GHD患者继发性不孕症发生率较高,明显高于对照组(p<0.05)。因此,可以认为这一因素可能会影响未来GHD的发展。第二组妇女使用捐赠卵子的频率(21.5%)明显高于第一组(4.9%)和对照组(5.3%)(p<0.05)。第一组和第二组分别有54.3%和45.1%的孕妇采用冷冻胚胎移植,与对照组(17.7%;p < 0.05)。这就有可能说明,使用捐赠卵子和移植冷冻保存的胚胎可能导致未来GHD发展的风险增加。在妊娠期AH的孕妇组中,遗传间隔期在10年及以上的患者明显更多。这提示较大的遗传间期可能对妊娠期高血压的进展有不利影响。结论。确定使用ART后妊娠妇女发生妊娠期高血压疾病的临床和临床旁危险因素——孕前动脉高血压、糖尿病、自身免疫性疾病、使用ART后多次妊娠,以及中度危险因素:“此伴侣”首次妊娠和患者年龄≥40岁。研究还确定了妊娠期高血压疾病发生的其他危险因素:既往妊娠的病理性分娩、继发性不孕、使用供体卵子、移植冷冻保存的胚胎、遗传间隔10年或更长。
{"title":"Probable clinical and paraclinical factors of the occurrence of gestational hypertensive disorders in pregnant women after the use of assisted reproductive technologies","authors":"O.V. Islamova, M. Kyrylchuk, L. Bulyk","doi":"10.30841/2708-8731.8.2022.273300","DOIUrl":"https://doi.org/10.30841/2708-8731.8.2022.273300","url":null,"abstract":"The objective: to establish probable clinical and paraclinical risk factors for the development of gestational hypertensive disorders (GHD) in pregnant women after the use of assisted reproductive technologies (ART).Materials and methods. A clinical and statistical analysis of the birth histories of 362 women who became pregnant after the use of ART was carried out. Among them, 103 patients with had pre-gestational arterial hypertension (AH) and were included in the 1st group, 51 patients with increased blood pressure for the first time after 20 weeks of pregnancy – GHD, were included in the 2nd group, and 208 women without hypertensive disorders (HD) neither before nor after pregnancy were included in the 3rd group (control one). To determine the prognostic value of probable clinical and paraclinical risk factors for the GHD development in patients after ART, the following factors were analyzed: place of residence, age during pregnancy, obstetric, gynecological and reproductive history, marriage status, body mass index. The assess of commonly known factors was also evaluated for the risk of development for GHD. The influence of method of artificial insemination is also considered.Statistical processing of the results was carried out using standard Microsoft Excel 7.0 and “Statistica 6.0” programs. Results. The research demonstrated that HD is a common complication in pregnant women after the use of ART and accounts for 42.5 %. The frequency of women ≥40 years old was significantly higher in the 1st (42.8 %) and 2nd (25.5 %) groups than in the 3d one (15.5 %), as well as the prevalence of secondary infertility among the examined female patients – 23.3 %, 37.2 % and 6.3 %, respectively. Diabetes was found in women of the 1st (7.8 %) and 2nd (5.9 %) groups statistically more often compared to the control group (1.9 %), multiple pregnancy – in 45.6 %, 52.9 % and 27.0 % cases, respectively; 11.8% of patients in the 2nd group were diagnosed with autoimmune diseases.In patients with pregestational AH and GHD there was the high frequency of secondary infertility which is significantly more compared to the control group (p<0.05). Therefore, it can be assumed that this factor may influence the development of GHD in the future.The use of donor eggs was significantly more frequent in women of the 2nd group (21.5 %) compared to patients of the 1st (4.9 %) and control (5.3 %) groups (p<0.05). Transfer of cryopreserved embryos was used in 54.3 % of pregnant women of the 1st group and in 45.1 % of pregnant women in the 2nd group, which is reliable compared to the indicators of the control group (17.7 %; p<0.05). This makes possible to state that the use of donor eggs and the transfer of cryopreserved embryos can lead to an increase in the risk of GHD development in the future.In the group of pregnant women with pregestational AH, there were significantly more patients with an intergenetic interval of 10 years or more. This suggests that a large intergenetic int","PeriodicalId":21003,"journal":{"name":"Reproductive health of woman","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73678811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Consequences of the war with the russian federation for the public health of Ukraine 与俄罗斯联邦的战争对乌克兰公共卫生的影响
Pub Date : 2022-12-29 DOI: 10.30841/2708-8731.8.2022.273291
І. Mironyuk, G. Slabkiy, О.S. Shcherbinska, V.J. Bilak-Lukianchuk
According to experts’ data, the war between Ukraine and Russia may become one of the bloodiest in modern history – the scale of losses on both sides is already much higher than in a typical war of the modern era. The objective: to determine the consequences of the war with the Russian Federation for the public health of Ukrainian population in the regions temporarily occupied by Russian army and located in the war zone.Materials and methods. The research materials were the data from scientific literature and personal practical experience in the organization of public health care. The method of the system approach, the bibliosemantic method and the method of structural and logical analysis were used. Results. The analysis of the was consequences with the Russian Federation for public health in the regions that are temporarily occupied and are located in the zone of active hostilities shows that they are complex and include medical-demographic, socio-economic and behavioral-biological groups. The main negative medico-demographic consequences include: an increase in the incidence of socially significant and infectious diseases, mental exhaustion with an increase in the level of psychological and mental problems with a high risk of post-traumatic stress disorder development with an increase in the general and premature mortality of the population without receiving medical help and self-medication and a high level of forced population migration. The main socio-economic consequences that negatively affect the state of public health include: the tragic loss of relative persons, housing and property, a decrease in the economic level of the population, the loss of social status of the large part of the population, a low level of access to the Internet and mobile communications connection or its complete absence (forced isolation), the significant damage of the infrastructure of the energy supply system for life, a low level of access to medical services and medicines. The main behavioral and biological consequences that negatively affect the state of public health include: the loss of previously stable conditions of quality life, living in unfavorable sanitary and hygienic conditions and in constant stress, the loss of motivation for behavior directed at a responsible attitude to personal health.Conclusions. The war with the Russian Federation has a significant negative impact on the state of public health in Ukraine.
根据专家的数据,乌克兰和俄罗斯之间的战争可能成为现代历史上最血腥的战争之一——双方的损失规模已经远远高于现代典型的战争。目的:确定与俄罗斯联邦的战争对俄罗斯军队暂时占领地区和战区乌克兰人口公共健康的影响。材料和方法。研究资料来源于科学文献和个人在公共卫生保健组织中的实践经验。本文采用了系统论方法、文献语义学方法和结构逻辑分析方法。结果。对俄罗斯联邦对暂时被占领地区和处于活跃敌对行动区的公共卫生的影响进行的分析表明,这些影响很复杂,包括医疗-人口、社会经济和行为-生物群体。主要的负面医学-人口后果包括:具有社会意义的疾病和传染病的发病率增加,精神疲惫,心理和精神问题的程度增加,创伤后应激障碍发展的高风险,没有得到医疗帮助和自我治疗的人口的一般死亡率和过早死亡率增加,以及人口的大量被迫移徙。对公共卫生状况产生负面影响的主要社会经济后果包括:亲属、住房和财产的悲惨损失,人口经济水平的下降,大部分人口的社会地位的丧失,互联网和移动通信连接的接入水平低或完全没有(被迫隔离),生活能源供应系统的基础设施严重受损,获得医疗服务和药品的水平低。对公共卫生状况产生负面影响的主要行为和生物学后果包括:失去以前稳定的高质量生活条件,生活在不利的卫生条件和持续的压力中,失去对个人健康负责任的行为动机。与俄罗斯联邦的战争对乌克兰的公共卫生状况产生了重大的负面影响。
{"title":"Consequences of the war with the russian federation for the public health of Ukraine","authors":"І. Mironyuk, G. Slabkiy, О.S. Shcherbinska, V.J. Bilak-Lukianchuk","doi":"10.30841/2708-8731.8.2022.273291","DOIUrl":"https://doi.org/10.30841/2708-8731.8.2022.273291","url":null,"abstract":"According to experts’ data, the war between Ukraine and Russia may become one of the bloodiest in modern history – the scale of losses on both sides is already much higher than in a typical war of the modern era. The objective: to determine the consequences of the war with the Russian Federation for the public health of Ukrainian population in the regions temporarily occupied by Russian army and located in the war zone.Materials and methods. The research materials were the data from scientific literature and personal practical experience in the organization of public health care. The method of the system approach, the bibliosemantic method and the method of structural and logical analysis were used. Results. The analysis of the was consequences with the Russian Federation for public health in the regions that are temporarily occupied and are located in the zone of active hostilities shows that they are complex and include medical-demographic, socio-economic and behavioral-biological groups. The main negative medico-demographic consequences include: an increase in the incidence of socially significant and infectious diseases, mental exhaustion with an increase in the level of psychological and mental problems with a high risk of post-traumatic stress disorder development with an increase in the general and premature mortality of the population without receiving medical help and self-medication and a high level of forced population migration. The main socio-economic consequences that negatively affect the state of public health include: the tragic loss of relative persons, housing and property, a decrease in the economic level of the population, the loss of social status of the large part of the population, a low level of access to the Internet and mobile communications connection or its complete absence (forced isolation), the significant damage of the infrastructure of the energy supply system for life, a low level of access to medical services and medicines. The main behavioral and biological consequences that negatively affect the state of public health include: the loss of previously stable conditions of quality life, living in unfavorable sanitary and hygienic conditions and in constant stress, the loss of motivation for behavior directed at a responsible attitude to personal health.Conclusions. The war with the Russian Federation has a significant negative impact on the state of public health in Ukraine.","PeriodicalId":21003,"journal":{"name":"Reproductive health of woman","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85315207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Peculiarities of clinical characteristics of pregnant with symptoms of Great obstetrical syndromes 有重大产科综合征症状的孕妇的临床特点
Pub Date : 2022-11-30 DOI: 10.30841/2708-8731.7.2022.272472
N. Lemish
The objective: to establish the risk factors for development of great obstetrical syndromes (GOS) on the basis of a prospective analysis of somatic, reproductive, obstetric anamnesis in pregnant women with clinical manifestations of GOSMaterials and methods. We conducted the analyses of somatic, reproductive and obstetrical history of 572 pregnant with clinical symptoms of GOS, who had the following complications: 21 – preeclampsia, 38 – preterm deliveries, 13 – placental abruption, 457 – gestational anemia, 27 – intrauterine growth retardation, 16 – fetal distress, that were diagnosed based on clinical, functional, laboratory, ultrasound, cardiotocographic and morphological investigations. All these complications are included in the group of GOS.Statistical analyze was conducted by using standard programs of Microsoft Excel 5.0 and Statistica 6.0.Results. The average age of the pregnant women was 26.5±2.3 years, most of them were in young reproductive age. The prevailing diseases in the structure of somatic pathology were thyroid gland pathology – 427 (74.6 %) persons, anemia 182 (31.8 %), arterial hypertension – 114 (19.9 %), kidney diseases – 241 (42.1 %) and diseases of gastro-intestinal tract –187 (32.7 %). Disorders of menstrual cycle were determined in 137 (23.9 %) women, chronic pelvic inflammatory diseases – 98 (17.1 %), background diseases of cervix (erosion, cervical dysplasia) had 142 (24.8 %) patients in anamnesis, colpitis – 296 (51.7 %), polycystic ovaries – 74 (12.9 %). The following pregnancy complications were diagnosed as preeclampsia – in 21 (3.7 %) persons, threatened preterm interruption of pregnancy in different gestational terms – in every third pregnant women (192 individuals – 33.7 %), anemia – 457 (79.9 %), preterm delivery – 38 (6.6 %) women, placental abruption – 13 (2.3 %), fetal growth retardation – in 27 cases (4.7 %), fetal distress – 16 (2.8 %). The rate of cesarean section in this group was 28.8 %.Conclusions. The identified peculiarities of somatic, reproductive history and obstetrical and perinatal pathology in pregnant with complications from GOS group allowed to define the following risk factors of their development: young reproductive age, significant frequency of socio-hygienic, medical and demographic and socio-psychological problems, complicated somatic, gynecological and reproductive history.
目的:在前瞻性分析有大产科综合征临床表现的孕妇躯体、生殖、产科记忆的基础上,探讨大产科综合征(GOS)发生的危险因素。我们对572例临床症状为GOS的孕妇的躯体、生殖和产科病史进行了分析,这些孕妇有以下并发症:先兆子痫21例,早产38例,胎盘早剥13例,妊娠贫血457例,宫内生长迟缓27例,胎儿窘迫16例,这些并发症均通过临床、功能、实验室、超声、心电和形态学检查诊断。以上并发症均归GOS组。采用Microsoft Excel 5.0和Statistica 6.0.Results标准程序进行统计分析。孕妇平均年龄为26.5±2.3岁,以年轻育龄妇女居多。躯体病理结构中的主要疾病是甲状腺病变427人(74.6%)、贫血182人(31.8%)、动脉高血压114人(19.9%)、肾脏疾病241人(42.1%)和胃肠道疾病187人(32.7%)。月经周期紊乱137例(23.9%),慢性盆腔炎98例(17.1%),宫颈背景疾病(糜烂、宫颈发育不良)142例(24.8%),阴道炎296例(51.7%),多囊卵巢74例(12.9%)。以下妊娠并发症被诊断为先兆子痫(21例(3.7%))、不同妊娠期有妊娠中断的威胁(每三名孕妇中有192例(33.7%))、贫血(457例(79.9%)、早产(38例(6.6%))、胎盘早剥(13例(2.3%))、胎儿发育迟缓(27例(4.7%)、胎儿窘迫(16例(2.8%))。本组剖宫产率为28.8%。从GOS组中发现的并发症孕妇的躯体、生殖史以及产科和围产期病理特点,可以确定其发展的以下危险因素:生育年龄小,社会卫生、医学、人口和社会心理问题的显著频率,复杂的躯体、妇科和生殖史。
{"title":"Peculiarities of clinical characteristics of pregnant with symptoms of Great obstetrical syndromes","authors":"N. Lemish","doi":"10.30841/2708-8731.7.2022.272472","DOIUrl":"https://doi.org/10.30841/2708-8731.7.2022.272472","url":null,"abstract":"The objective: to establish the risk factors for development of great obstetrical syndromes (GOS) on the basis of a prospective analysis of somatic, reproductive, obstetric anamnesis in pregnant women with clinical manifestations of GOSMaterials and methods. We conducted the analyses of somatic, reproductive and obstetrical history of 572 pregnant with clinical symptoms of GOS, who had the following complications: 21 – preeclampsia, 38 – preterm deliveries, 13 – placental abruption, 457 – gestational anemia, 27 – intrauterine growth retardation, 16 – fetal distress, that were diagnosed based on clinical, functional, laboratory, ultrasound, cardiotocographic and morphological investigations. All these complications are included in the group of GOS.Statistical analyze was conducted by using standard programs of Microsoft Excel 5.0 and Statistica 6.0.Results. The average age of the pregnant women was 26.5±2.3 years, most of them were in young reproductive age. The prevailing diseases in the structure of somatic pathology were thyroid gland pathology – 427 (74.6 %) persons, anemia 182 (31.8 %), arterial hypertension – 114 (19.9 %), kidney diseases – 241 (42.1 %) and diseases of gastro-intestinal tract –187 (32.7 %). Disorders of menstrual cycle were determined in 137 (23.9 %) women, chronic pelvic inflammatory diseases – 98 (17.1 %), background diseases of cervix (erosion, cervical dysplasia) had 142 (24.8 %) patients in anamnesis, colpitis – 296 (51.7 %), polycystic ovaries – 74 (12.9 %). The following pregnancy complications were diagnosed as preeclampsia – in 21 (3.7 %) persons, threatened preterm interruption of pregnancy in different gestational terms – in every third pregnant women (192 individuals – 33.7 %), anemia – 457 (79.9 %), preterm delivery – 38 (6.6 %) women, placental abruption – 13 (2.3 %), fetal growth retardation – in 27 cases (4.7 %), fetal distress – 16 (2.8 %). The rate of cesarean section in this group was 28.8 %.Conclusions. The identified peculiarities of somatic, reproductive history and obstetrical and perinatal pathology in pregnant with complications from GOS group allowed to define the following risk factors of their development: young reproductive age, significant frequency of socio-hygienic, medical and demographic and socio-psychological problems, complicated somatic, gynecological and reproductive history.","PeriodicalId":21003,"journal":{"name":"Reproductive health of woman","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80385762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Hormonal homeostasis in women of reproductive age with adenomyosis 育龄期b子宫腺肌症妇女的激素稳态
Pub Date : 2022-11-30 DOI: 10.30841/2708-8731.7.2022.272463
V. O. Beniuk, V. Kurochka, K.I. Susak, Y. Drupp, O. Bălă
The problem of adenomyosis is particularly relevant for patients of reproductive age, as it is accompanied by the significant disturbances of menstrual and generative functions. The article presents the results of studying the condition of the hypothalamic-pituitary-ovarian system in women of reproductive age with adenomyosis.The objective: to study the state of the hypothalamic-pituitary-ovarian system in women of reproductive age with benign endometrial and myometrial pathology.Materials and methods. The main group included 120 women of reproductive age with benign endometrial and myometrial pathology (adenomyosis, endometrial hyperplasia and combined pathology), and the control group included 40 healthy women without gynecological pathology. The functional state of the hypothalamic-pituitary-ovarian system was evaluated by the levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), prolactin (PRL), estradiol (E2) and progesterone (P) in blood serum in different phases of the menstrual cycle.Results. In women with adenomyosis, endometrial hyperplasia and combined pathology, there is hyperproduction of gonadotropic hormones with an increase of their secretion level compared to a group of healthy women: the average concentration of FSH, regardless of the phase of the menstrual cycle, increased by 1.9 times (p<0.05), LH – 2.2 times, PRL – 2 times, which indicates the presence of hyperprolactinemia. Both in the I and II phases of the menstrual cycle, the occurrence of additional FSH and LH peaks from basal hormone secretion was determined in patients of the main group, which reached the level of hormone concentration in the ovulatory peak. In the patients of the main group, hyperestrogenemia during the entire menstrual cycle and hypoprogesteronemia were detected. The expression of hormonal shifts depended on gynecological pathology (adenomyosis, endometrial hyperplasia and combined pathology) and the functional state of the woman.Conclusions. The indicators of gonadotropic and prolactin-stimulating activity of the pituitary gland in women with benign uterine pathology confirm the participation of FSH, LH and prolactin in the complex processes of regulation of the reproductive system.
子宫腺肌病的问题是特别相关的育龄患者,因为它是伴随着月经和生殖功能的显著干扰。本文介绍了育龄妇女子宫腺肌病的下丘脑-垂体-卵巢系统状况的研究结果。目的:探讨良性子宫内膜和子宫肌瘤病理的育龄妇女下丘脑-垂体-卵巢系统的状态。材料和方法。主要组为子宫内膜及子宫肌瘤良性病理(子宫腺肌症、子宫内膜增生及合并病理)的育龄妇女120例,对照组为无妇科病理的健康妇女40例。采用促卵泡激素(FSH)、黄体生成素(LH)、催乳素(PRL)、雌二醇(E2)、黄体酮(P)水平评价月经周期各阶段下丘脑-垂体-卵巢系统的功能状态。在子宫腺肌病、子宫内膜增生及合并病理的女性中,促性腺激素的分泌量与健康女性相比增高,且促性腺激素分泌水平增高:不论月经周期的哪个阶段,FSH平均浓度升高1.9倍(p<0.05), LH -升高2.2倍,PRL -升高2倍,提示存在高催乳素血症。主组患者在月经周期I期和II期均有基础激素分泌增加FSH和LH峰,达到排卵期激素浓度水平。主组患者在整个月经周期均出现高雌激素血症和低孕激素血症。激素转移的表达与妇科病理(子宫腺肌症、子宫内膜增生及合并病理)和妇女的功能状态有关。良性子宫病理女性垂体促性腺和促泌乳素活性指标证实FSH、LH和催乳素参与生殖系统复杂的调节过程。
{"title":"Hormonal homeostasis in women of reproductive age with adenomyosis","authors":"V. O. Beniuk, V. Kurochka, K.I. Susak, Y. Drupp, O. Bălă","doi":"10.30841/2708-8731.7.2022.272463","DOIUrl":"https://doi.org/10.30841/2708-8731.7.2022.272463","url":null,"abstract":"The problem of adenomyosis is particularly relevant for patients of reproductive age, as it is accompanied by the significant disturbances of menstrual and generative functions. The article presents the results of studying the condition of the hypothalamic-pituitary-ovarian system in women of reproductive age with adenomyosis.The objective: to study the state of the hypothalamic-pituitary-ovarian system in women of reproductive age with benign endometrial and myometrial pathology.Materials and methods. The main group included 120 women of reproductive age with benign endometrial and myometrial pathology (adenomyosis, endometrial hyperplasia and combined pathology), and the control group included 40 healthy women without gynecological pathology. The functional state of the hypothalamic-pituitary-ovarian system was evaluated by the levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), prolactin (PRL), estradiol (E2) and progesterone (P) in blood serum in different phases of the menstrual cycle.Results. In women with adenomyosis, endometrial hyperplasia and combined pathology, there is hyperproduction of gonadotropic hormones with an increase of their secretion level compared to a group of healthy women: the average concentration of FSH, regardless of the phase of the menstrual cycle, increased by 1.9 times (p<0.05), LH – 2.2 times, PRL – 2 times, which indicates the presence of hyperprolactinemia. Both in the I and II phases of the menstrual cycle, the occurrence of additional FSH and LH peaks from basal hormone secretion was determined in patients of the main group, which reached the level of hormone concentration in the ovulatory peak. In the patients of the main group, hyperestrogenemia during the entire menstrual cycle and hypoprogesteronemia were detected. The expression of hormonal shifts depended on gynecological pathology (adenomyosis, endometrial hyperplasia and combined pathology) and the functional state of the woman.Conclusions. The indicators of gonadotropic and prolactin-stimulating activity of the pituitary gland in women with benign uterine pathology confirm the participation of FSH, LH and prolactin in the complex processes of regulation of the reproductive system.","PeriodicalId":21003,"journal":{"name":"Reproductive health of woman","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77045804","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
To the question of the clinical predictive value of the sFlt-1:PlGF ratio is related to the placental dysfunction 关于sFlt-1:PlGF比值是否与胎盘功能障碍有关的临床预测价值问题
Pub Date : 2022-11-30 DOI: 10.30841/2708-8731.7.2022.272468
A. Pylypenko, V. Medved
The objective: to evaluate the clinical and prognostic value and meaning of the ratio of the anti-angiogenic factor of soluble fms-like tyrosine kinase-1 (sFlt-1) to the angiogenic factor of the placental growth factor (PlGF) in the dynamics of pregnancy as markers of various variants of placental dysfunction. Materials and methods. A retrospective cohort study of 40 pregnant women, who were distributed by gestation term (up to 34 weeks and after 34 weeks) and the level of sFlt-1:PlGF ratio (<38 is low level, > 110 – high level) was performed. The statistical comparison of the sFlt-1:PlGF ratio with the development of hypertensive disorders during pregnancy and fetal growth retardation (FGR), as well as the duration of the period from research to childbirth was calculated. Results. Preeclampsia (PE) developed in 12 persons out of 40 pregnant women. The sFlt-1:PlGF ratio in the period till 27 weeks of pregnancy in groups of women with PE and without it does not differ with a statistically significant level (p=0.3). In other gestation terms the sFlt-1:PlGF ratio in women with and without placental dysfunction is statistically significant (p<0.05). The sFlt-1:PlGF ratio >38 increases the risk of PE more than 4 times (RR = 4.6) and is statistically significant in a period till 34 weeks [95 % CI: 1.4-14,9]. After 34 weeks of pregnancy the sFlt-1:PlGF ratio >110 has a higher sensitivity (Se=0.75).An analysis of the sFlt-1:PlGF ratio for the purpose of FGR predicting, both in combination with hypertensive disorders during pregnancy or without them, demonstrated its high importance during pregnancy up to 34 weeks (p=0.001). A strong reverse correlation (ƿ= -0.7) was found between the value of the sFlt-1:PlGF ratio and the number of days from the date of research till childbirth at the level of significance of 0.0001 in pregnant women up to 34 weeks. Conclusions. The predictive value of the conventional method of assessing the preeclampsia (PE) risk and the preventive efficiency of acetylsalicylic acid is low. In the absence of clinical manifestation of PE the determination of the sFlt-1:PlGF ratio for a predication till 27 weeks of pregnancy is not informative, so it is not recommended. If the sFlt-1:PlGF ratio is > 38 in the period till 34 weeks, the relative risk is 4.6 [95 % CI: 1.4–14.9]. If the level of the sFlt-1:PlGF ratio is high at first investigation there is no sense to repeat the research in dynamics. In the case of low the sFlt-1:PlGF ratio for a reasonable suspicion of PE development, repeated research can help make an adequate clinical decision. The determination of the sFlt-1:PlGF ratio for a predication or confirmation of fetal growth retardation till 34 weeks is clinically reasonable and informative. There is a strong reverse correlation between the sFlt-1:PlGF ratio and the number of days before the current birth.
目的:评价妊娠动力学中可溶性类纤维酪氨酸激酶-1 (sFlt-1)抗血管生成因子与胎盘生长因子(PlGF)血管生成因子比值作为胎盘功能障碍各种变异的标志物的临床及预后价值和意义。材料和方法。对40名孕妇进行回顾性队列研究,这些孕妇按妊娠期(34周以内和34周后)和sFlt-1:PlGF比值(110 -高水平)进行分布。计算sFlt-1:PlGF比值与妊娠期高血压疾病的发生、胎儿生长迟缓(FGR)以及从研究到分娩持续时间的统计比较。结果。先兆子痫(PE)在40名孕妇中有12人发展。妊娠27周前,PE组与非PE组的sFlt-1:PlGF比值无统计学差异(p=0.3)。在其他妊娠期,有和无胎盘功能障碍的妇女的sFlt-1:PlGF比值具有统计学意义(p38使PE的风险增加4倍以上(RR = 4.6),并且在34周之前具有统计学意义[95% CI: 1.4-14,9]。妊娠34周后,sFlt-1:PlGF比值>110敏感性较高(Se=0.75)。一项用于FGR预测的sFlt-1:PlGF比值分析显示,在妊娠期合并高血压疾病或未合并高血压疾病时,其在妊娠34周内具有很高的重要性(p=0.001)。sFlt-1:PlGF比值的值与从研究日期到分娩的天数之间存在很强的负相关(±0.7),在怀孕至34周的妇女中,显著性水平为0.0001。结论。传统方法评估子痫前期(PE)风险的预测价值和乙酰水杨酸的预防效果较低。在没有PE临床表现的情况下,测定sFlt-1:PlGF比值对妊娠27周前的预测没有帮助,因此不推荐使用。如果在34周内sFlt-1:PlGF比值> 38,则相对风险为4.6 [95% CI: 1.4-14.9]。如果第一次调查时sFlt-1:PlGF比率水平很高,那么在动力学上重复研究是没有意义的。在sFlt-1:PlGF比值较低的情况下,合理怀疑PE的发展,反复研究有助于做出充分的临床决策。测定sFlt-1:PlGF比值预测或确认胎儿生长迟缓至34周在临床上是合理且有价值的。sFlt-1:PlGF比值与当前出生前天数之间存在很强的负相关关系。
{"title":"To the question of the clinical predictive value of the sFlt-1:PlGF ratio is related to the placental dysfunction","authors":"A. Pylypenko, V. Medved","doi":"10.30841/2708-8731.7.2022.272468","DOIUrl":"https://doi.org/10.30841/2708-8731.7.2022.272468","url":null,"abstract":"The objective: to evaluate the clinical and prognostic value and meaning of the ratio of the anti-angiogenic factor of soluble fms-like tyrosine kinase-1 (sFlt-1) to the angiogenic factor of the placental growth factor (PlGF) in the dynamics of pregnancy as markers of various variants of placental dysfunction. Materials and methods. A retrospective cohort study of 40 pregnant women, who were distributed by gestation term (up to 34 weeks and after 34 weeks) and the level of sFlt-1:PlGF ratio (<38 is low level, > 110 – high level) was performed. The statistical comparison of the sFlt-1:PlGF ratio with the development of hypertensive disorders during pregnancy and fetal growth retardation (FGR), as well as the duration of the period from research to childbirth was calculated. Results. Preeclampsia (PE) developed in 12 persons out of 40 pregnant women. The sFlt-1:PlGF ratio in the period till 27 weeks of pregnancy in groups of women with PE and without it does not differ with a statistically significant level (p=0.3). In other gestation terms the sFlt-1:PlGF ratio in women with and without placental dysfunction is statistically significant (p<0.05). The sFlt-1:PlGF ratio >38 increases the risk of PE more than 4 times (RR = 4.6) and is statistically significant in a period till 34 weeks [95 % CI: 1.4-14,9]. After 34 weeks of pregnancy the sFlt-1:PlGF ratio >110 has a higher sensitivity (Se=0.75).An analysis of the sFlt-1:PlGF ratio for the purpose of FGR predicting, both in combination with hypertensive disorders during pregnancy or without them, demonstrated its high importance during pregnancy up to 34 weeks (p=0.001). A strong reverse correlation (ƿ= -0.7) was found between the value of the sFlt-1:PlGF ratio and the number of days from the date of research till childbirth at the level of significance of 0.0001 in pregnant women up to 34 weeks. Conclusions. The predictive value of the conventional method of assessing the preeclampsia (PE) risk and the preventive efficiency of acetylsalicylic acid is low. In the absence of clinical manifestation of PE the determination of the sFlt-1:PlGF ratio for a predication till 27 weeks of pregnancy is not informative, so it is not recommended. If the sFlt-1:PlGF ratio is > 38 in the period till 34 weeks, the relative risk is 4.6 [95 % CI: 1.4–14.9]. If the level of the sFlt-1:PlGF ratio is high at first investigation there is no sense to repeat the research in dynamics. In the case of low the sFlt-1:PlGF ratio for a reasonable suspicion of PE development, repeated research can help make an adequate clinical decision. The determination of the sFlt-1:PlGF ratio for a predication or confirmation of fetal growth retardation till 34 weeks is clinically reasonable and informative. There is a strong reverse correlation between the sFlt-1:PlGF ratio and the number of days before the current birth.","PeriodicalId":21003,"journal":{"name":"Reproductive health of woman","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90143604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The results of personificated ovarian cancer patients with peritoneal carcinomatosis treatment 人格化卵巢癌患者腹膜癌病的治疗结果
Pub Date : 2022-11-30 DOI: 10.30841/2708-8731.7.2022.272470
A. Rybin
The objective: to analyse of the experience of cytoreductive surgery using and hypenermic intraperitoneal chemperfusion (HIPEC) in patients with ovarian cancer IIIC stage, as well as overall and relapse-free survival in such patients. Materials and methods. 119 patients with ovarian cancer of the IIIC stage were involved into the study from 2013 to 2020 and they were treated at the University Clinic of Odessa National Medical University. Patients were divided into two groups: the clinical control group (n=53) included persons after suboptimal cytoreduction; the patients of the main group (n=66) had optimal or complete cytoreduction, and in some cases with subsequent intraoperative hyperthermic intraperitoneal chemotherapy. During the initial analysis of these groups, time (preoperative period, duration of surgery, number of postoperative bed-days), as well as the presence of complications in the postoperative period were determined. Results. In the main group there was an increase operation time due to large surgery volumes and the implementation of the HIPEC procedure with primary cytoreduction (p=0.001). In the postoperative period, an increase in the number of bed-days in the hospital in patients of the main group in relation to the control group was established, especially in those who had HIPEC (p=0.001). There was an increase in the number of surgical complications of class III-IV according to the Clavien-Dindo classification (from 5 % to 22.2 %) in patients after HIPEC. An increase in relapse-free survival from 10 months in the control group to 13-19 months in the main group was revealed. The recurrence median in the postoperative period in the control group was 10±1.3 months, and after interval cytoreduction and primary cytoreduction with HIPEC – 13±1.5 and 19±6.3 months, respectively. The index of relapse-free survival in the first 6 months in the control group was 63.2 %, in patients after optimal or complete cytoreduction – 88.0 %, in patients after optimal or complete cytoreduction and HIPEC – 90.4 %. One-year recurrence-free survival rate was 37.5 %, 63.2 % and 60.1 %, respectively, the average values of overall survival – 27.7±4.1 months versus 24.5±1.8 and 24.1±2.2 months, respectively. Conclusions. Cytoreductive surgery and methods of intraoperative hyperthermic intraperitoneal chemotherapy are perspective options of treatment of patients with peritoneal carcinomatosis by ovarian cancer regarding recurrence of the disease and survival, although they are accompanied by more postoperative complications and number of bed-days in hospital.
目的:分析IIIC期卵巢癌患者行细胞减少术和低低温腹腔化学灌注(HIPEC)的经验,以及此类患者的总生存期和无复发生存期。材料和方法。2013年至2020年,119名IIIC期卵巢癌患者参与了这项研究,他们在敖德萨国立医科大学大学诊所接受了治疗。患者分为两组:临床对照组(n=53)包括细胞减少不理想的患者;主组患者(n=66)有最佳或完全的细胞减少,并在一些病例中进行了术中腹腔内高热化疗。在对这些组进行初步分析时,确定时间(术前时间、手术时间、术后卧床天数)以及术后并发症的发生情况。结果。在主组中,由于大手术量和HIPEC手术的实施伴有原发性细胞减少,手术时间增加(p=0.001)。在术后期间,与对照组相比,主要组患者住院天数增加,特别是HIPEC患者(p=0.001)。根据Clavien-Dindo分类,HIPEC后患者III-IV级手术并发症的数量增加(从5%增加到22.2%)。无复发生存期由对照组的10个月增加到主组的13-19个月。对照组术后中位复发率为10±1.3个月,HIPEC间歇细胞减少术和原发性细胞减少术的复发率分别为13±1.5个月和19±6.3个月。对照组前6个月无复发生存率为63.2%,最佳或完全细胞减少组为88.0%,最佳或完全细胞减少组和HIPEC组为90.4%。1年无复发生存率分别为37.5%、63.2%和60.1%,总生存期平均值分别为27.7±4.1个月、24.5±1.8个月和24.1±2.2个月。结论。细胞减少手术和术中腹腔热化疗方法是卵巢癌腹膜癌患者术后并发症和住院天数较多的治疗方法,但从疾病复发和生存的角度来看,它们是治疗卵巢癌腹膜癌患者的理想选择。
{"title":"The results of personificated ovarian cancer patients with peritoneal carcinomatosis treatment","authors":"A. Rybin","doi":"10.30841/2708-8731.7.2022.272470","DOIUrl":"https://doi.org/10.30841/2708-8731.7.2022.272470","url":null,"abstract":"The objective: to analyse of the experience of cytoreductive surgery using and hypenermic intraperitoneal chemperfusion (HIPEC) in patients with ovarian cancer IIIC stage, as well as overall and relapse-free survival in such patients. Materials and methods. 119 patients with ovarian cancer of the IIIC stage were involved into the study from 2013 to 2020 and they were treated at the University Clinic of Odessa National Medical University. Patients were divided into two groups: the clinical control group (n=53) included persons after suboptimal cytoreduction; the patients of the main group (n=66) had optimal or complete cytoreduction, and in some cases with subsequent intraoperative hyperthermic intraperitoneal chemotherapy. During the initial analysis of these groups, time (preoperative period, duration of surgery, number of postoperative bed-days), as well as the presence of complications in the postoperative period were determined. Results. In the main group there was an increase operation time due to large surgery volumes and the implementation of the HIPEC procedure with primary cytoreduction (p=0.001). In the postoperative period, an increase in the number of bed-days in the hospital in patients of the main group in relation to the control group was established, especially in those who had HIPEC (p=0.001). There was an increase in the number of surgical complications of class III-IV according to the Clavien-Dindo classification (from 5 % to 22.2 %) in patients after HIPEC. An increase in relapse-free survival from 10 months in the control group to 13-19 months in the main group was revealed. The recurrence median in the postoperative period in the control group was 10±1.3 months, and after interval cytoreduction and primary cytoreduction with HIPEC – 13±1.5 and 19±6.3 months, respectively. The index of relapse-free survival in the first 6 months in the control group was 63.2 %, in patients after optimal or complete cytoreduction – 88.0 %, in patients after optimal or complete cytoreduction and HIPEC – 90.4 %. One-year recurrence-free survival rate was 37.5 %, 63.2 % and 60.1 %, respectively, the average values of overall survival – 27.7±4.1 months versus 24.5±1.8 and 24.1±2.2 months, respectively. Conclusions. Cytoreductive surgery and methods of intraoperative hyperthermic intraperitoneal chemotherapy are perspective options of treatment of patients with peritoneal carcinomatosis by ovarian cancer regarding recurrence of the disease and survival, although they are accompanied by more postoperative complications and number of bed-days in hospital.","PeriodicalId":21003,"journal":{"name":"Reproductive health of woman","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86707791","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Prediction of the development of fetal growth retardation in pregnant women with chronic arterial hypertension 慢性动脉性高血压孕妇胎儿发育迟缓的预测
Pub Date : 2022-11-30 DOI: 10.30841/2708-8731.7.2022.272466
O. Deinichenko, V.G. Sіusіuka, Y. Krut, M. Pavlyuchenko, O.D. Kyryliuk, N.Y. Boguslavska
During intrauterine life a fetus with growth restriction does hemodynamic, metabolic and hormonal adjustments to cope with the adverse uterine environment, and these changes can become permanent and irreversible. Despite the progress in the knowledge of delayed fetal development, the biomarkers are able to identify this pathology at an early stage and stratify its severity, both before and after childbirth, are still not determined. The objective: to evaluate the prognostic value of the angiogenesis marker level, hormonal profile and Doppler examination for fetal growth restriction (FGR) in pregnant women with chronic arterial hypertension (CAH).Materials and methods. A prospective examination of 61 pregnant women with CAH 1-2 degrees was conducted, which included an analysis of the clinical and anamnestic characteristics and the study of the pregnancy course in the first trimester (11-12 weeks). To determine the level of risk factors for the FGR development the examined pregnant women were divided into groups: women with CAH with FGR (n=10), and pregnant women with CAH without FGR (n=51).Human chorionic gonadotropin (CHG), progesterone (PG) and estradiol (E) were determined in blood serum. Angiogenesis markers – placental growth factor (P1GF) as a pro-angiogenic factor and soluble fms-like tyrosine kinase (sFlt-1) as an anti-angiogenic factor were studied, the ratio of sFlt-1/PLGF (coefficient K) was calculated. All patients had Doppler examination of vascular blood flow in the left and right uterine arteries (pulsation index – PI, resistance index – RI and systolic-diastolic ratio – SDR). The ultrasound examination was done with the ultrasound machine “Mylab Six System”. Statistical analysis was performed using program Statistica® for Windows 13.0. A single-factor logistic regression analysis and a method of building logistics regression, which was evaluated by means of receive operating characteristic curve (ROC-curve) according to the area under the curve (AUC) were used to determine the prognostic level of markers, the 95 % confidence interval was calculated. Results. In the first trimester of pregnancy in women with CAH the PLGF level was < 8.2 pg/ml (sensitivity – 80.0 %, specificity – 60.78 %), area under the ROC curve (AUC) – 0.697 (95 % CI: 0.566–0.808; p =0.0128), which indicate an increased risk of FGR development. The growth of sFl-1 > 1802.59 ng/ml (sensitivity – 70.0 %, specificity – 64.71 %), area under the ROC-curve (AUC) 0.678 (95 % CI: 0.547–0.792; p=0.05) increase the risk of FGR development. The coefficient K in 11-12 weeks of pregnancy was ≥ 95.36 units (sensitivity – 100.0 %, specificity – 43.14 %), area under ROC-curve (AUC) – 0.735 (95 % CI: 0.607–0.840; p=0.0128), which indicate an increase the risk of FGR development. PG/PlGF ratio is 7.21 (sensitivity – 70.0 %, specificity – 70.59 %) and area under the ROC-curve (AUC) 0.702 (95 % CI: 0.571–0.812; p = 0.0118) also indicate the increase the risk of FGR development, as we
在宫内生活中,生长受限的胎儿通过血液动力学、代谢和激素调节来应对不利的子宫环境,这些变化可能是永久性的和不可逆转的。尽管在胎儿发育迟缓的知识方面取得了进展,但生物标志物能够在早期阶段识别这种病理,并在分娩前后对其严重程度进行分层,但仍未确定。目的:探讨血管生成标志物水平、激素谱及多普勒检查对慢性动脉高血压(CAH)孕妇胎儿生长受限(FGR)的预后价值。材料和方法。对61例CAH 1-2度孕妇进行前瞻性检查,分析其临床和记忆特征,并对妊娠早期(11-12周)的妊娠过程进行研究。为了确定FGR发生的危险因素水平,将接受检查的孕妇分为两组:CAH合并FGR的孕妇(n=10)和CAH合并FGR的孕妇(n=51)。测定血清中人绒毛膜促性腺激素(CHG)、孕酮(PG)和雌二醇(E)。研究促血管生成因子胎盘生长因子(P1GF)和抗血管生成因子可溶性膜样酪氨酸激酶(sFlt-1),计算sFlt-1/PLGF比值(系数K)。所有患者均行多普勒检查左、右子宫动脉血管血流(搏动指数PI、阻力指数RI、收缩舒张比SDR)。超声检查采用“Mylab Six System”超声机。统计分析使用Statistica®程序为Windows 13.0。采用单因素logistic回归分析和建立logistic回归的方法,根据曲线下面积(AUC),用roc曲线评价指标的预后水平,计算95%置信区间。结果。CAH患者妊娠早期PLGF水平< 8.2 pg/ml(敏感性- 80.0%,特异性- 60.78%),ROC曲线下面积(AUC) - 0.697 (95% CI: 0.566-0.808;p =0.0128),这表明FGR发展的风险增加。sFl-1 >的生长1802.59 ng/ml(敏感性- 70.0%,特异性- 64.71%),roc曲线下面积(AUC) 0.678 (95% CI: 0.547 ~ 0.792;p=0.05)会增加FGR发生的风险。妊娠11 ~ 12周时K系数≥95.36单位(敏感性为100.0%,特异性为43.14%),roc曲线下面积(AUC)为0.735 (95% CI: 0.607 ~ 0.840;p=0.0128),这表明FGR发展的风险增加。PG/PlGF比值为7.21(敏感性- 70.0%,特异性- 70.59%),roc曲线下面积(AUC)为0.702 (95% CI: 0.571-0.812;p = 0.0118)以及E/PLGF比值> 138.53(敏感性- 100.0%,特异性- 35.29%)和roc曲线下面积(AUC) 0.640 (95% CI: 0.507 ~ 0.759)也表明FGR发展的风险增加。在存在诱发FGR的危险因素的情况下,CAH孕妇的多普勒结果显示,各组患者的CDR差异不明显:CAH合并FGR组(n=10) CDR为3.62±0.09单位,CAG合并FGR组(n=51) CDR为3.71±0.05单位;左子宫动脉分别为3.63±0.09单位和3.71±0.05单位(p 1802.59 ng/ml,系数K≥95.36单位,PG/PlGF > 7.21单位,E/PlGF > 138.53单位,CHG/PlGF≥30.14单位)。CAG孕妇FGR风险将在随后确定,妊娠11-12周时CDR和RI的显著变化尚未确定,但随着右子宫动脉PI增加超过1.84单位,左子宫动脉PI增加超过1.82单位,FGR将进一步发展。
{"title":"Prediction of the development of fetal growth retardation in pregnant women with chronic arterial hypertension","authors":"O. Deinichenko, V.G. Sіusіuka, Y. Krut, M. Pavlyuchenko, O.D. Kyryliuk, N.Y. Boguslavska","doi":"10.30841/2708-8731.7.2022.272466","DOIUrl":"https://doi.org/10.30841/2708-8731.7.2022.272466","url":null,"abstract":"During intrauterine life a fetus with growth restriction does hemodynamic, metabolic and hormonal adjustments to cope with the adverse uterine environment, and these changes can become permanent and irreversible. Despite the progress in the knowledge of delayed fetal development, the biomarkers are able to identify this pathology at an early stage and stratify its severity, both before and after childbirth, are still not determined. The objective: to evaluate the prognostic value of the angiogenesis marker level, hormonal profile and Doppler examination for fetal growth restriction (FGR) in pregnant women with chronic arterial hypertension (CAH).Materials and methods. A prospective examination of 61 pregnant women with CAH 1-2 degrees was conducted, which included an analysis of the clinical and anamnestic characteristics and the study of the pregnancy course in the first trimester (11-12 weeks). To determine the level of risk factors for the FGR development the examined pregnant women were divided into groups: women with CAH with FGR (n=10), and pregnant women with CAH without FGR (n=51).Human chorionic gonadotropin (CHG), progesterone (PG) and estradiol (E) were determined in blood serum. Angiogenesis markers – placental growth factor (P1GF) as a pro-angiogenic factor and soluble fms-like tyrosine kinase (sFlt-1) as an anti-angiogenic factor were studied, the ratio of sFlt-1/PLGF (coefficient K) was calculated. All patients had Doppler examination of vascular blood flow in the left and right uterine arteries (pulsation index – PI, resistance index – RI and systolic-diastolic ratio – SDR). The ultrasound examination was done with the ultrasound machine “Mylab Six System”. Statistical analysis was performed using program Statistica® for Windows 13.0. A single-factor logistic regression analysis and a method of building logistics regression, which was evaluated by means of receive operating characteristic curve (ROC-curve) according to the area under the curve (AUC) were used to determine the prognostic level of markers, the 95 % confidence interval was calculated. Results. In the first trimester of pregnancy in women with CAH the PLGF level was < 8.2 pg/ml (sensitivity – 80.0 %, specificity – 60.78 %), area under the ROC curve (AUC) – 0.697 (95 % CI: 0.566–0.808; p =0.0128), which indicate an increased risk of FGR development. The growth of sFl-1 > 1802.59 ng/ml (sensitivity – 70.0 %, specificity – 64.71 %), area under the ROC-curve (AUC) 0.678 (95 % CI: 0.547–0.792; p=0.05) increase the risk of FGR development. The coefficient K in 11-12 weeks of pregnancy was ≥ 95.36 units (sensitivity – 100.0 %, specificity – 43.14 %), area under ROC-curve (AUC) – 0.735 (95 % CI: 0.607–0.840; p=0.0128), which indicate an increase the risk of FGR development. PG/PlGF ratio is 7.21 (sensitivity – 70.0 %, specificity – 70.59 %) and area under the ROC-curve (AUC) 0.702 (95 % CI: 0.571–0.812; p = 0.0118) also indicate the increase the risk of FGR development, as we","PeriodicalId":21003,"journal":{"name":"Reproductive health of woman","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82862566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Reproductive health of woman
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1